Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 18.121% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCO/C=C1\SC(=S)N(c2ccc(Cl)cc2)C1=O
b Cc1csc2nc3cc(C(N)=O)ccc3c(=O)n12
c COc1ccc(NC(=O)CN(Cc2ccco2)Cc2ccco2)cc1S(=O)(=O)N1CCCCC1
Answer: a. CCO/C=C1\SC(=S)N(c2ccc(Cl)cc2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCO/C=C1\SC(=S)N(c2ccc(Cl)cc2)C1=O
CCO/C=C1\SC(=S)N(c2ccc(Cl)cc2)C1=O
(5Z)-3-(4-chlorophenyl)-5-(ethoxymethylidene)-2-sulfanylidene-1,3-thiazolidin-4-one